Medical Procedure News

RSS

People with kidney stones more likely to need dialysis or transplant later in life

People who have had kidney stones are twice as likely to need dialysis or a kidney transplant later in life, demonstrates recently published findings by medical researchers at the University of Alberta. Their article was recently published in the British Medical Journal.

7 Sep 2012

PCI after lung cancer treatment reduces risk of brain metastases in stage III NSCLC patients

Stage III non-small cell lung cancer (NSCLC) patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial irradiation (PCI); however, this study did not show an improvement in overall survival with PCI, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

7 Sep 2012

Study finds excellent outcomes for patients with acute liver failure after LDLT

Patients in Japan who underwent living donor liver transplantation (LDLT) for acute liver failure (ALF) were classified as having excellent outcomes, with ten-year survival at 73%.

7 Sep 2012

Race, marital status can impact survival rates of patients with Stage III non-small cell lung cancer

A study of survival data for Stage III, non-small cell lung cancer (NSCLC) patients at the University of Maryland's Greenebaum Cancer Center in Baltimore indicates that marital status and race can significantly impact patient survival rates, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

7 Sep 2012

Q Therapeutics licenses Neuralstem's Spinal Cord Delivery Platform and Floating Cannula

Neuralstem, Inc. announced that it has granted the first licenses for use of its Spinal Cord Delivery Platform and Floating Cannula, for delivering therapeutic agents to the spinal cord, to Salt Lake City-based Q Therapeutics.

7 Sep 2012

Estech introduces COBRA Fusion ablation system

Estech, a leading provider of minimally invasive cardiac ablation devices, today announced the market release of its COBRA Fusion ablation system.

6 Sep 2012

Thomas Jefferson University Hospitals performs 500th Whipple procedure

Thomas Jefferson University Hospital continues to be the leader in the region in fighting the deadliest of cancers—pancreatic cancer. In August, Charles J. Yeo, MD, FACS, the Samuel D. Gross Professor and Chair of Surgery, and a co-director of the Jefferson Pancreas, Biliary and Related Cancer Center, performed his 500th Whipple procedure at Thomas Jefferson University Hospitals, a life-saving surgery for those suffering with the disease.

6 Sep 2012

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Antibiotics are medicines used to treat infections or diseases caused by bacteria, such as some respiratory tract infections (including pneumonia and whooping cough), urinary tract infections, skin infections and infected wounds.

6 Sep 2012

Chemotherapy increases risk of mild cognitive deficits in breast cancer patients

A large meta-analysis conducted by researchers at Moffitt Cancer Center has concluded that breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits after treatment.

6 Sep 2012

Patients at hospitals with longer resuscitation attempts have higher survival rates

There isn't a hard and fast rule for how long doctors should perform CPR, but new research from the University of Michigan Health System shows longer attempts might be beneficial for some patients.

6 Sep 2012

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

A team of scientists led by a bone marrow transplant researcher at Fred Hutchinson Cancer Research Center has shed new light on why most bone marrow transplant patients who receive tissue-matched cells from unrelated donors still suffer acute graft-versus-host disease (GVHD).

6 Sep 2012

Endovascular repair for abdominal aortic aneurysms has low rate of complications

A minimally invasive procedure known as endovascular repair used for abdominal aortic aneurysms has a low rate of complications, even in high-risk patients such as those with kidney, heart or lung problems, a Mayo Clinic study shows.

6 Sep 2012

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately.

5 Sep 2012

Longer resuscitation could be beneficial after in-hospital cardiac arrest

New research published Online First in The Lancet suggests that increasing the duration of resuscitation efforts could improve survival in patients who arrest in hospital, challenging the common belief that extending resuscitation in patients who do not respond immediately is often futile.

5 Sep 2012

OptiMedica Catalys Precision Laser System for creating corneal incisions receives FDA 510(k) clearance

Global ophthalmic company OptiMedica Corp. has announced U.S. Food and Drug Administration 510(k) market clearance of its Catalys Precision Laser System for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.

5 Sep 2012

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

VIDA Diagnostics, a leading developer of quantitative imaging analysis software for the diagnosis and treatment planning of major pulmonary disease, announced today the release and commercial availability of Apollo 1.2, here at the European Respiratory Society (ERS) meeting in Vienna, Austria.

3 Sep 2012

ImThera Medical announces results from targeted hypoglossal neurostimulation study on OSA

ImThera Medical, Inc. today announced that results from the first single-center study of targeted hypoglossal neurostimulation (THN) for obstructive sleep apnea (OSA) will appear in an upcoming print edition of the European Respiratory Journal.

3 Sep 2012

Gene therapy approach restores ability to smell in mouse model of congenital anosmia

Scientists funded by the National Institutes of Health have restored the ability to smell in a mouse model of a human genetic disorder that causes congenital anosmia-the inability to smell from birth. The approach uses gene therapy to regrow cilia, cell structures that are essential for olfactory function.

3 Sep 2012

Scientists restore sense of smell in mice through gene therapy

Scientists have restored the sense of smell in mice through gene therapy for the first time -- a hopeful sign for people who can't smell anything from birth or lose it due to disease.

3 Sep 2012

Nurses, midwives can safely perform abortions, review of evidence suggests

"Abortions are just as safe when performed by trained nurse practitioners, midwives and physician assistants as when doctors do them, a new review of the evidence suggests," Reuters reports.

1 Sep 2012

Medical Procedure News

People with kidney stones more likely to need dialysis or transplant later in life

PCI after lung cancer treatment reduces risk of brain metastases in stage III NSCLC patients

Study finds excellent outcomes for patients with acute liver failure after LDLT

Race, marital status can impact survival rates of patients with Stage III non-small cell lung cancer

Q Therapeutics licenses Neuralstem's Spinal Cord Delivery Platform and Floating Cannula

Estech introduces COBRA Fusion ablation system

Thomas Jefferson University Hospitals performs 500th Whipple procedure

Antibiotics: facts and fictions: an interview with Dr Philippa Binns, clinical adviser at NPS MedicineWise

Chemotherapy increases risk of mild cognitive deficits in breast cancer patients

Patients at hospitals with longer resuscitation attempts have higher survival rates

Study sheds new light on why most bone marrow transplant patients suffer acute GVHD

Endovascular repair for abdominal aortic aneurysms has low rate of complications

European regulators approve Surefire Infusion System for chemo- and radioembolization procedures

Longer resuscitation could be beneficial after in-hospital cardiac arrest

OptiMedica Catalys Precision Laser System for creating corneal incisions receives FDA 510(k) clearance

VIDA releases Apollo 1.2 SaaS for endobronchial emphysema treatment

ImThera Medical announces results from targeted hypoglossal neurostimulation study on OSA

Gene therapy approach restores ability to smell in mouse model of congenital anosmia

Scientists restore sense of smell in mice through gene therapy

Nurses, midwives can safely perform abortions, review of evidence suggests

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News